HPV & Screening
HPV and Cervical Cancer Screening Guide
O
Op. Dr. Berrak Beyoglu Oruc·April 2, 2026·9 min readA clear guide to Pap smear, HPV DNA testing, colposcopy, CIN, LEEP, HPV vaccination, and HPV-related health risks in men.
Share
Guide Intro
HPV and cervical cancer screening is one of the strongest areas of preventive women's health care. The goal is not only to diagnose cancer after it develops, but to identify risky HPV infections and precancerous cellular changes early enough to guide safe follow-up and timely treatment.
This guide brings together the key topics from Pap smear and HPV DNA screening to colposcopy, CIN classification, LEEP, HPV vaccination, and HPV-related effects in men. The content is educational and should not replace individual medical evaluation.
1
Topic
What Is a Pap Smear and When Is It Performed?
Pap smear is a simple, quick, and usually painless screening test used to detect precancerous cell changes and cervical cancer at an early stage. During a gynecologic examination, a small sample of cells is collected from the cervix with a special brush and sent to pathology for microscopic evaluation. The aim is not primarily to diagnose invasive cancer, but to detect cellular abnormalities before cancer develops.
Pap smear screening is generally recommended after sexual activity begins. Turkey's national cervical cancer screening program and international guidance such as ASCCP share the same preventive goal, but they differ in age range and preferred screening method. In the national Turkish program, primary HPV DNA testing is the main method between the ages of 30 and 65, while cytology is used mainly as a triage tool in HPV-positive patients. In many international algorithms, cytology-based screening begins earlier and HPV-based screening becomes more central after age 25.
To improve test accuracy, Pap smear should not be performed during menstruation. Vaginal medication, intercourse, and vaginal douching are generally avoided for 24 to 48 hours before the test. With regular screening, cervical cancer becomes a largely preventable disease because precancerous changes can be followed or treated before cancer develops.
WARNING BOX: Screening Notes
- Routine screening between ages 21 and 25 usually relies on cytology rather than HPV DNA testing.
- After age 25, HPV DNA becomes the primary screening method in many guidelines.
- If screening is performed with smear alone, repeating the test every 3 years is generally appropriate.
- Turkey's national screening program often starts cervical screening at age 30, while some international guidelines begin at age 25.
- Yearly Pap smear is not required for every low-risk patient in routine screening.
- Pap smear should not be collected during menstruation; the preferred timing is after bleeding ends.
- Screening may be stopped after age 65 in appropriately screened patients or after total hysterectomy for a benign reason.
2
Topic
Where Can Screening Tests Be Performed?
In Turkey, cervical cancer screening is widely available within the national screening program coordinated by the Ministry of Health. Screening can be performed at KETEM centers, family health centers, and women's health clinics. Samples collected for smear or HPV DNA testing are sent to reference laboratories for analysis.
Family health centers are an important first step for patients who do not have symptoms but need routine screening. KETEM units and gynecology clinics not only collect samples but also help coordinate follow-up. If an abnormal result is identified, the patient can then be referred to gynecology for further evaluation and treatment planning.
This organized system aims to increase participation in screening and reduce cervical cancer-related illness and death by identifying risky cases before symptoms appear.
3
Topic
What Is an HPV DNA Test?
HPV DNA testing is a screening method used to detect the presence of human papillomavirus, especially high-risk types that play a central role in the development of cervical cancer. Unlike Pap smear, which looks for cellular abnormalities, HPV DNA testing looks for the genetic material of the virus itself before visible cell damage may appear.
The test is performed during a gynecologic examination with a cervical brush, much like a smear sample. It is short, usually painless, and the collected sample is analyzed with molecular techniques in the laboratory. High-risk types such as HPV 16 and 18 may be reported separately because of their stronger cancer association.
Because HPV DNA testing has high sensitivity, it is used as a primary screening method in many countries. A negative result is reassuring and usually allows longer screening intervals. A positive result does not mean cancer is present; it means that closer follow-up, reflex cytology, or colposcopy may be needed.
WARNING BOX: HPV and Transmission
- Follow-up depends on which HPV type is detected and whether cytology is normal or abnormal.
- Condoms reduce transmission risk but do not provide complete protection because skin-to-skin contact can also spread HPV.
- Vaccination before sexual debut offers the strongest protection.
4
Topic
What Happens If HPV Is Positive?
A positive HPV DNA result does not mean that the patient has cervical cancer. It means that HPV has been detected on the cervix and that the patient may need closer follow-up. HPV is extremely common in sexually active people, and many infections are cleared spontaneously within 1 to 2 years by the immune system.
HPV types are grouped according to cancer risk. HPV 16 and 18 are the most important high-risk types and are responsible for a large proportion of cervical cancers. Other types such as 31, 33, 45, 52, and 58 are also considered high-risk. Low-risk types such as HPV 6 and 11 are usually associated with genital warts rather than cancer.
Management after a positive result depends on the HPV type and any accompanying smear findings. HPV 16 or 18 positivity often leads directly to colposcopic evaluation even when cytology is normal, because the risk of precancerous lesions is higher. In other high-risk HPV groups, smear results help determine whether repeat testing, closer follow-up, or colposcopy is appropriate.
WARNING BOX: HPV Types
- Highest oncogenic risk: HPV 16 and HPV 18.
- Other high-risk types: 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, 82.
- Low-risk and wart-associated types: 6, 11, 40, 42, 43, 44.
5
Topic
What Is Colposcopy?
Colposcopy is a detailed examination of the cervix, vagina, and sometimes the vulva using a magnifying device called a colposcope. It is most commonly recommended after abnormal smear or HPV results. The aim is to identify suspicious areas that cannot be seen clearly with the naked eye.
During the procedure, the patient is placed in the usual gynecologic examination position and a speculum is inserted. The colposcope stays outside the body and simply provides light and magnification. Acetic acid and Lugol iodine are often applied to the cervix to make abnormal areas more visible.
If needed, small biopsies can be taken during colposcopy. These samples allow definitive pathological diagnosis. Colposcopy is not an operation; it is an advanced office-based evaluation that plays a key role in preventing cervical cancer by guiding early diagnosis and selective treatment.
6
Topic
What Do CIN 1, CIN 2, and CIN 3 Mean?
CIN stands for cervical intraepithelial neoplasia. It is a pathology term used to describe precancerous changes in the cells that line the surface of the cervix. CIN lesions are usually identified after biopsy obtained during colposcopy.
CIN 1 represents mild change and usually affects only the lower third of the cervical epithelium. It is often linked to transient HPV infection and frequently regresses spontaneously, so careful follow-up is usually preferred over immediate excisional treatment.
CIN 2 shows a more moderate degree of abnormality and may involve up to two thirds of the epithelial thickness. CIN 3 represents severe abnormality involving nearly the full thickness of the epithelium. CIN 3 is not cancer, but because the risk of progression is higher, excisional treatment such as LEEP or conization is often recommended.
7
Topic
What Is the LEEP Procedure?
LEEP, or loop electrosurgical excision procedure, is a treatment used to remove precancerous cervical tissue and at the same time obtain a specimen for pathology. A thin wire loop carrying electrical energy is used to excise the abnormal area in a controlled way.
It is commonly recommended in higher-grade lesions such as CIN 2 and CIN 3. The procedure is generally short and can be performed under local anesthesia or sedation depending on the patient and the clinical setting. Most patients return home the same day.
After LEEP, light bleeding, brown discharge, or spotting may continue for a few weeks. Intercourse, tampons, and vaginal douching are usually avoided for several weeks to reduce infection risk. Follow-up with smear and HPV testing remains important because persistent HPV infection may still require long-term monitoring.
8
Topic
Who Should Receive the HPV Vaccine?
HPV vaccination is a preventive vaccine designed to reduce disease caused by HPV, especially cervical cancer and genital warts. The currently available 9-valent vaccine protects against HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58. It is preventive rather than therapeutic, so it offers the strongest benefit when given before HPV exposure.
The vaccine is especially recommended for girls and boys between the ages of 9 and 14. In this group, the immune response is strong and 2 doses are generally sufficient. Vaccination is not limited to adolescence, however, and can still be useful later in life for many individuals who have not previously been vaccinated.
Vaccination is also recommended in many adults between 15 and 45 years, depending on clinical context and local guidance. Even sexually active patients, or those who may already have encountered one HPV type, can still benefit because they are unlikely to have been exposed to every vaccine-covered type. A positive HPV result or an abnormal smear is not, by itself, a reason to avoid vaccination.
Even after vaccination, screening must continue because the vaccine does not cover every HPV type. Today, HPV vaccination together with screening is one of the most effective preventive strategies against cervical cancer.
WARNING BOX: Key Vaccine Notes
- HPV vaccination is an important public health tool for both girls and boys.
- Adults may also receive the vaccine when appropriate.
- Two doses are generally used between ages 9 and 14, and three doses from age 15 onward.
- Protection is strongest when vaccination is completed before HPV exposure.
- HPV vaccine is not a live vaccine and does not cause active infection.
- Natural infection does not guarantee lasting antibody protection; vaccination still adds preventive value.
- Vaccination can be planned regardless of HPV DNA result in appropriate patients.
- Smear and HPV screening should continue even after vaccination.
- Condoms reduce transmission risk but do not fully prevent HPV spread because skin contact can also transmit the virus.
9
Topic
What Does HPV Do in Men?
HPV is not limited to women. It is also a very common infection in men, and many men encounter the virus at some point in life. Most infections are cleared by the immune system without causing symptoms, but some persist and may lead to genital warts or, more rarely, cancer.
The most common HPV-related problem in men is genital warts, especially those caused by HPV 6 and 11. These lesions may develop on the penis, scrotum, groin, or around the anus. They are benign but contagious, and they may enlarge or spread if left untreated.
High-risk HPV types, especially 16 and 18, are also associated with penile cancer, anal cancer, and oropharyngeal cancers. Vaccination is one of the most effective preventive measures for men as well. Although condoms help reduce transmission, they do not completely eliminate risk, so awareness and timely evaluation of suspicious lesions remain important.
Important Note
The content is for informational purposes; definitive diagnosis and treatment require physician evaluation.
Tags
#Pregnancy#Nutrition#Women Health#HPV & Screening
Op. Dr. Berrak Beyoglu Oruc
Obstetrics and Gynecology Specialist
I care about offering each patient a personalized, clear, and reassuring follow-up and treatment plan in women’s health, pregnancy care, and surgical processes.
View All Posts ->You May Also Like
Would You Like an Appointment?
Get professional support for your health concerns; let’s plan the right care journey together.
Request Appointment